Science Explorer Back to mapMap
Discussion
Topic · Epidemiology

Adipokines, Inflammation, and Metabolic Diseases

Adipokines, Inflammation, and Metabolic Diseases is a research topic within Epidemiology. Science Explorer counts 48k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the intricate relationship between inflammation and obesity, focusing on the impact of chronic inflammation in adipose tissue on the development of obesity-related metabolic disorders such as insulin resistance, cardiovascular disease, and type 2 diabetes. The role of adipokines, macrophage accumulation, and C-reactive protein in linking inflammation to metabolic syndrome is also extensively studied.

  • Inflammation
  • Obesity
  • Adipose Tissue
  • Insulin Resistance
  • Cardiovascular Disease
  • Adipokines
  • Macrophages
  • C-Reactive Protein
  • Metabolic Syndrome
  • Type 2 Diabetes
Research works
48k
fractional, since 1950
In the world top 10%
4.8k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+6%
the tick is no change
Largest producer
China
40% of the 10 largest, 2022-now
Adipokines, Inflammation, and Metabolic Diseases

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Adipokines, Inflammation, and Metabolic Diseases research?

By volume, China and the United States publish the most (2.7k and 1.4k works in 2022-now).

By volume, 2022-now

  1. 1 China 2.7k works
  2. 2 United States 1.4k works
  3. 3 India 520 works
  4. 4 Iran 331 works
  5. 5 Türkiye 322 works
  6. 6 South Korea 305 works
  7. 7 Japan 290 works
  8. 8 Germany 286 works
  9. 9 Italy 248 works
  10. 10 Spain 231 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 40.5%United States: 21.5%India: 7.8%Iran: 5.0%6 others listed: 25.2%40%largest
China2,701 · 40.5%United States1,437 · 21.5%India520 · 7.8%Iran331 · 5.0%6 others listed1,683 · 25.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Adipokines, Inflammation, and Metabolic Diseases research?

By volume in 2022-now, Harvard University publishes the most Adipokines, Inflammation, and Metabolic Diseases research, followed by Shanghai Jiao Tong University and Capital Medical University.

Who are the leading researchers in Adipokines, Inflammation, and Metabolic Diseases?

The most-cited researchers publishing on Adipokines, Inflammation, and Metabolic Diseases include Eric S. Lander, George Davey Smith and Ali H. Mokdad.

  1. 1 Eric S. Lander United States 524k citations
  2. 2 George Davey Smith United Kingdom 435k citations
  3. 3 Ali H. Mokdad United States 429k citations
  4. 4 Walter Churchill Willett United States 411k citations
  5. 5 Stacey L. Gabriel United States 402k citations
  6. 6 Robert John Tibshirani United States 396k citations
  7. 7 John J.V. McMurray United Kingdom 349k citations
  8. 8 Hermann Brenner Germany 343k citations
  9. 9 Shizuo Akira Japan 342k citations
  10. 10 Cyrus Cooper United Kingdom 342k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Adipokines, Inflammation, and Metabolic Diseases?

The most cited paper in Adipokines, Inflammation, and Metabolic Diseases is "Atherosclerosis — An Inflammatory Disease" (Russell Ross, 1999), with 21,815 citations. Next come "Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance" (10,985) and "Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease" (9,517).

Most cited papers
#PaperReleasedCitations
1 Atherosclerosis — An Inflammatory Disease Russell Ross · New England Journal of Medicine 14 Jan 1999 21,815
2 Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance Jaakko O. Tuomilehto, Jaana Lindström, Johan Gunnar Eriksson et al. · New England Journal of Medicine Open access 3 May 2001 10,985
3 Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease Paul M. Ridker et al. · New England Journal of Medicine Open access 27 Aug 2017 9,517
4 Inflammation and metabolic disorders Gökhan S. Hotamışlıgil · Nature 13 Dec 2006 9,214
5 Inflammation, Atherosclerosis, and Coronary Artery Disease Göran K. Hansson · New England Journal of Medicine 20 Apr 2005 8,822
All 96 most cited papers, with filters and sorting

Where is Adipokines, Inflammation, and Metabolic Diseases research done?

The largest centres of Adipokines, Inflammation, and Metabolic Diseases research in 2022-now are Beijing (China), Shanghai (China), Guangzhou (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Giessen.

Largest cities, 2022-now

  1. 1 BeijingChina 346 works
  2. 2 ShanghaiChina 197 works
  3. 3 GuangzhouChina 159 works
  4. 4 SeoulSouth Korea 133 works
  5. 5 TehranIran 122 works
  6. 6 NanjingChina 114 works
  7. 7 ChengduChina 97 works
  8. 8 WuhanChina 92 works
  9. 9 HangzhouChina 91 works
  10. 10 MoscowRussia 81 works

Where it is the local speciality

  1. GiessenDE · 23.1 works6.4×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Adipokines, Inflammation, and Metabolic Diseases than the world average.

See Adipokines, Inflammation, and Metabolic Diseases on the map

Where is the best place to study Adipokines, Inflammation, and Metabolic Diseases?

Among universities, judged by research, Harvard University, University of Copenhagen and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 16.34%fractional works in this field (log) →share of work in the world top 10% →Harvard UniversityUniversity of Copenh…Shanghai Jiao Tong U…Chinese Academy of M…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 84.922.7%2.6×73 +0.5%
2University of CopenhagenDenmark 67.717.0%3.8×31 +23.4%
3Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 65.913.7%7.1×65 +78.8%
4Shanghai Jiao Tong UniversityChina 65.716.9%2.7×68 +46.4%
5Capital Medical UniversityChina 64.012.3%7.2×67 +78.9%
6Southern Medical UniversityChina 62.517.4%7.0×38 +88.4%
7Sun Yat-sen UniversityChina 61.316.5%2.6×46 +33.6%
8Nanjing Medical UniversityChina 59.912.6%6.8×53 +41.5%
9Peking UniversityChina 59.619.7%2.0×35 +52.7%
10Central South UniversityChina 59.514.6%2.9×48 +25.7%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Adipokines, Inflammation, and Metabolic Diseases, country by country

Is Adipokines, Inflammation, and Metabolic Diseases research growing?

Output in 2022-2025 was 6% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Adipokines, Inflammation, and Metabolic Diseases.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Adipokines, Inflammation, and Metabolic Diseases as a percentage of every work published that year, 0.038% in 2024.

still counting0.020%0.040%0.060%Adipokines, Inflammation, and Metabolic Diseases0.042% in 202519801990200020102020

Fractional works of Adipokines, Inflammation, and Metabolic Diseases over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Adipokines, Inflammation, and Metabolic Diseases10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Adipokines, Inflammation, and Metabolic Diseases. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.